Write a reviewFor vendors
♡
Home / Investors / David Bonita

David Bonita

Venture Fund · New York City

About David Bonita

Venture capital investor (General Partner) based in New York City, New York. Focus areas include Health Care, Research and Development, Drug Discovery. Invests at seed, series a stage. Past investments include Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma.

Investment focus

Stages
SeedSeries A
Sectors
Health CareResearch and DevelopmentDrug DiscoveryWellnessRare DiseasesInvestment ManagementHealthcare InnovationStrategic PartnershipsLife SciencePortfolio ManagementMedical TechnologiesInformation Technology (IT)Venture FundraisingMobileFinanceBiotechnologyHealthcare ITMedical DevicesDrug DevelopmentElectronic Health Records (EHR)

Portfolio

No portfolio companies recorded yet; David Bonita reports 60 investments overall.

Similar investors

Aaref Hilaly

Angel Investor · San Francisco
SeedSeries BEarly Stage VentureSeries AHealth CareData IntegrationTalent ManagementE-commerce+16
60Investments
—Exits

Aaron Bast

Venture Fund · Kitchener
SeedEarly Stage VentureAdvertisingHealth CareAccountingPayments+16
60Investments
—Exits

Abbie Celniker

Venture Fund · Newton
SeedHealth CareDrug DiscoveryAutoimmune DiseasesWellness+16
60Investments
—Exits

Abhinaya Konduru

Venture Fund · Chicago
SeedPre-SeedEarly Stage VentureHealth CareE-commercePaymentsCybersecurity+16
60Investments
—Exits

Adam Cragg

Angel Investor · Calgary
SeedPre-SeedEarly Stage VentureSeries AAdvertisingHealth CareCybersecurityEnterprise Software+16
60Investments
—Exits

Adam Rothenberg

Angel Investor · New York City
SeedPre-SeedEarly Stage VentureSeries AHealth CareE-commerceMessagingDisruptive Innovation+16
60Investments
—Exits